|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Clinical Care/Education/Nutrition |
Plasma and Dietary Vitamin E in Relation to Incidence of Type 2 Diabetes
The Insulin Resistance and Atherosclerosis Study (IRAS)
1 Department of Epidemiology and Biostatistics, Norman J. Arnold School of Public Health, University of South Carolina, Columbia, South Carolina
2 PHS Core Laboratory, Fred Hutchinson Cancer Research Center, Seattle, Washington
3 Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
OBJECTIVE—To evaluate the association of vitamin E with incidence of type 2 diabetes and to do so separately among individuals who did and those who did not report regular use of vitamin supplementation.
RESEARCH DESIGN AND METHODS—The Insulin Resistance Atherosclerosis Study (IRAS) included 895 nondiabetic adults at baseline (including 303 with impaired glucose tolerance [IGT]), 148 of whom developed type 2 diabetes according to World Health Organization (WHO) criteria during the 5-year follow-up. At baseline, dietary vitamin E was estimated by a validated food frequency interview, usual supplement use was confirmed by supplement label, and plasma 
-tocopherol was measured. Analyses were conducted separately for individuals who did (n = 318) and did not (n = 577) use vitamin E supplements.
RESULTS—Among supplement nonusers, reported mean intake of vitamin E (mg -tocopherol equivalents [-TE]) did not differ between those who remained nondiabetic (n = 490) and those who developed diabetes (n = 87) (10.5 ± 5.5 vs. 9.5 ± 4.8 [means ± SD], respectively, NS). After adjustment for demographic variables, obesity, physical activity, and other nutrients, the association remained nonsignificant (odds ratio [OR] 0.80, 95% CI 0.13–5.06) for the highest level of intake (
20 mg -TE) compared with the lowest level (1–4 -TE). However, results for plasma concentration of -tocopherol showed a significant protective effect both before and after adjustment for potential confounders (adjusted OR 0.12, 95% CI 0.02–0.68, for the highest quintile vs. the lowest quintile; overall test for trend, P < 0.01). Among individuals who reported habitual use of vitamin E supplements (at least once per month in the year before baseline; 259 remained nondiabetic and 59 developed diabetes), no protective effect was observed for either reported intake of vitamin E or plasma concentration of -tocopherol
CONCLUSIONS—A protective effect of vitamin E may exist within the range of intake available from food. This effect may go undetected within studies of high-dose supplement use, which appears to hold no additional protective benefit.
Abbreviations: -TE, -tocopherol equivalents • FFQ, food frequency questionnaire • IGT, impaired glucose tolerance • IRAS, Insulin Resistance and Atherosclerosis Study • OR, odds ratio
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Stranges, J. R. Marshall, R. Natarajan, R. P. Donahue, M. Trevisan, G. F. Combs, F. P. Cappuccio, A. Ceriello, and M. E. Reid Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial Ann Intern Med, August 21, 2007; 147(4): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, I-M. Lee, Y. Song, M. Van Denburgh, N. R. Cook, J. E. Manson, and J. E. Buring Vitamin E and Risk of Type 2 Diabetes in the Women's Health Study Randomized Controlled Trial. Diabetes, October 1, 2006; 55(10): 2856 - 2862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gao, A. Martin, H. Lin, O. I. Bermudez, and K. L. Tucker {alpha}-Tocopherol Intake and Plasma Concentration of Hispanic and Non-Hispanic White Elders Is Associated with Dietary Intake Pattern J. Nutr., October 1, 2006; 136(10): 2574 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Czernichow, A. Couthouis, S. Bertrais, A.-C. Vergnaud, L. Dauchet, P. Galan, and S. Hercberg Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 395 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gao, P. E. Wilde, A. H. Lichtenstein, O. I. Bermudez, and K. L. Tucker The Maximal Amount of Dietary {alpha}-Tocopherol Intake in U.S. Adults (NHANES 2001-2002) J. Nutr., April 1, 2006; 136(4): 1021 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Song, J. E. Manson, J. E. Buring, H. D. Sesso, and S. Liu Associations of Dietary Flavonoids with Risk of Type 2 Diabetes, and Markers of Insulin Resistance and Systemic Inflammation in Women: A Prospective Study and Cross-Sectional Analysis J. Am. Coll. Nutr., October 1, 2005; 24(5): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Montonen, P. Knekt, R. Jarvinen, and A. Reunanen Dietary Antioxidant Intake and Risk of Type 2 Diabetes Diabetes Care, February 1, 2004; 27(2): 362 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D Liese, A. K Roach, K. C Sparks, L. Marquart, R. B D'Agostino Jr, and E. J Mayer-Davis Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study Am. J. Clinical Nutrition, November 1, 2003; 78(5): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden American Diabetes Association Annual Meeting, June 2003: Gastrointestinal and dietary aspects of diabetes Diabetes Care, October 1, 2003; 26(10): 2941 - 2946. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |